NOV 20, 2019 12:27 PM PST

New diagnostic technology seeks out cancer DNA in blood

WRITTEN BY: Tara Fernandez

For many cancers, early detection has a tremendous impact on patient outcomes. Yet, sadly, many of the most common malignancies, like those of the stomach, colon, liver, breast, and lung, still lack robust diagnostic tests.

In a recent TEDx Talk, Dr. Anne Marie Lennon presented exciting clinical findings from testing a new molecular diagnostic platform developed by herself and colleagues at Johns Hopkins University. This cutting edge technology, called CancerSEEK, has the potential of being a game-changer for catching cancer earlier, by accurately detecting trace amounts of cancer DNA with a simple blood test.

Lennon, a medical doctor and Associate Professor of Medicine at Johns Hopkins, is an expert in early cancer detection and prevention, having authored over 100 peer-reviewed papers on the topic.

The problem with spotting cancer molecules circulating in the bloodstream is that they are present only in extremely minute quantities. As Lennon describes it: it’s like finding a needle in a haystack. For every 10,000 DNA fragments in a cancer patient’s blood sample, only between 1 and 5 of those are mutated sequences, indicative of the presence of disease.

The first iteration of the platform, known as Safe-SeqS, used a DNA barcode attached to a single mutant DNA template as a means to gauge the system’s sensitivity. Sequencing DNA in blood draws from cancer patients and healthy controls revealed that Safe-SeqS could positively identify around 30 percent of those taken from pancreatic cancer sufferers.

This was in itself a major milestone, considering no early detection strategies for pancreatic cancer currently exist and consequently, only 7 percent of diagnosed patients survive the disease.

In a bid to improve Safe-SeqS’ diagnostic capabilities, the researchers took a two-fold approach towards designing CancerSEEK. This new platform combed liquid biopsies, picking up both tumor DNA as well as other known molecular markers associated with a variety of common cancers. This system doubled its hit rate with a median of 70 percent of cancer samples correctly identified, with no false-positive hits for healthy controls.

Among CancerSEEK’s most impressive scores was a 98 percent positive discovery of samples from patients with liver and ovarian cancers.

On a positive note, CancerSEEK looks to have a clear path to becoming a routine part of medical care, with the inventors already hauling in $110 million in investment dollars to commercialize the technology.

Sources: TEDx Talks, Johns Hopkins University

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 28, 2020
Cancer
Protecting the Head and Neck from Off Target Radiation
OCT 28, 2020
Protecting the Head and Neck from Off Target Radiation
Radiotherapy alone or with chemotherapy is the go-to treatment for head and neck cancers. Unfortunately, head and neck t ...
OCT 24, 2020
Clinical & Molecular DX
Software Flags Elevated Cerebral Palsy Risk in Premies
OCT 24, 2020
Software Flags Elevated Cerebral Palsy Risk in Premies
Diagnostic imaging scientists have developed a software tool for predicting the future onset of cerebral palsy in babies ...
NOV 11, 2020
Clinical & Molecular DX
Smart Mask Detects COVID Infections, Sends Alert to Phone
NOV 11, 2020
Smart Mask Detects COVID Infections, Sends Alert to Phone
  This week, the Centers for Disease Control and Prevention issued new guidance to put the “mask debate&rdquo ...
JAN 26, 2021
Cell & Molecular Biology
Diagnostic Tool Could ID 20% of Autism Cases
JAN 26, 2021
Diagnostic Tool Could ID 20% of Autism Cases
Scientists may have created a diagnostic test that can identify as many as one-fifth of potential autism spectrum disord ...
JAN 26, 2021
Genetics & Genomics
Why Only Some People With a Rare Mutation Get a Heart Condition
JAN 26, 2021
Why Only Some People With a Rare Mutation Get a Heart Condition
Scientists have found a way to explain why a heart condition called hypertrophic cardiomyopathy (HCM) can be so differen ...
FEB 15, 2021
Clinical & Molecular DX
Asking Patients the Right Questions About Their Symptoms
FEB 15, 2021
Asking Patients the Right Questions About Their Symptoms
A patient is admitted to the hospital after experiencing chest pains. What are the right questions that hospital staff a ...
Loading Comments...